Scleroderma-related interstitial lung disease
| Autor: | Rafael L. Perez, Sally Suliman, Jesse Roman, Abdalhamid Al Harash, William Neil Roberts |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty medicine.medical_treatment Case Report Systemic inflammation Scleroderma Pulmonary fibrosis 03 medical and health sciences Progressive systemic sclerosis 0302 clinical medicine medicine 030212 general & internal medicine Slow disease progression Intensive care medicine skin and connective tissue diseases 030203 arthritis & rheumatology lcsh:RC705-779 integumentary system business.industry Interstitial lung disease Immunosuppression lcsh:Diseases of the respiratory system respiratory system medicine.disease respiratory tract diseases Clinical trial Respiratory failure Immunology medicine.symptom business |
| Zdroj: | Respiratory Medicine Case Reports Respiratory Medicine Case Reports, Vol 22, Iss C, Pp 109-112 (2017) |
| ISSN: | 2213-0071 |
| Popis: | Scleroderma-related interstitial lung disease (SSc-ILD) is a pulmonary fibrosing disorder characterized by systemic inflammation and progressive scarring of the lungs that leads to respiratory failure. Although certain immunosuppressive therapies may slow disease progression, current treatment strategies are not curative; consequently, SSc-ILD continues to be a major cause of morbidity and mortality. We present four cases of SSc-ILD that emphasize the importance of early screening and detection, close follow-up, and aggressive management. We also highlight the need for well-conducted clinical trials designed to identify new and effective treatments. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|